"This study confirms that even with improved [treatment to reduce bleeding], hemophilia A has a non-negligible impact on healthcare system costs," researchers wrote in the study, "Population-Level Real-World Healthcare Costs in Men and Women With […]
"This study confirms that even with improved [treatment to reduce bleeding], hemophilia A has a non-negligible impact on healthcare system costs," researchers wrote in the study, "Population-Level...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
"This study confirms that even with improved [treatment to reduce bleeding], hemophilia A has a non-negligible impact on healthcare system costs," researchers wrote in the study, "Population-Level Real-World Healthcare Costs in Men and Women With […]
Open the app view to save this story, compare related coverage, and continue from the same source.